Ticker ABIO – ARCA Biopharma – sales, description, marketcap – Tickerday.com

ABIO

ARCA Biopharma

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 26.16M; Volume: 61.14K; AvgVol 3m: 1.01M; Beta: 2.88;

Cost estimate:

P/E: –; EPS: -3.08; EPS growth quarter/prev quarter: 36.10%;

EPS growth this year: 59.80%; EPS growth past 5 years: 41.30%;

EPS ttm: -3.08;

P/S: ; P/B: 0.90; P/Cashflow: 2.71; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -53.30%; ROE – return on equity: -60.60%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.30%; Insider Transactions:104.49%;

Institutional Ownership: 8.60%; Institutional Transactions: 157.52%;

Data update: 07/10/2020.